Ifosfamide appears to act similarly to other alkylating agents. Its active metabolites interfere with DNA replication and transcription of RNA, thereby disrupting nucleic acid function. It is cycle-phase nonspecific.
Imidocarb is approved for use to treat _Babesia canis_ infections (babesiosis) in dogs, but the drug may also be efficacious against _Ehrlichia canis_ in this species. Imidocarb may be of benefit in treating Babesia and related parasitic diseases in a variety of domestic and exotic animals. Imidocarb appears to be more effective against _B. canis_ than _B. gibsoni_ .
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
必須由獸醫腫瘤團隊確認物種、精確腫瘤診斷與分期、既往治療、共病、器官功能及同步藥物。 任何考慮使用都必須重新核對精確成品、調配與處置條件、給予方式、輔助措施、監測、停用規則及緊急處置。 犬與貓研究的數值只能留在各自研究情境，不得跨物種、跨腫瘤、跨階段、跨成品或跨研究設計轉移。 在完整獸醫臨床契約與主審批准前，系統不得計算、開立、輸出或建立自動交互作用。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
renal